>

>

Immuno-oncology competitive intelligence

Service Areas
Therapeutic Areas

Oncology

Client Type

Mid-size Biotech

Client Problems

  • A mid-size biotech company has an immuno-oncology therapy with a new MOA in clinical trials


  • They want to determine the current and future landscape for immuno-oncology products, especially with unique MOAs


  • Gain insights from competitors clinical trials and launches and create a differentiation strategy

What We Did

  • Identified all the current players in the immuno-oncology space and stratified them their drug candidates according to MOA, lines of therapy, indications, mono vs combo therapies.


  • Analyzed their clinical trials and determine the trial size, patient segmentation and biomarker strategy


  • Determined the approvals and launches of the competitors products


  • Created a differentiation strategy

Our Results And Insight

  • Emerging immuno-oncology and new therapeutic MOA candidates clinical trials landscape


  • Competitor approvals and anticipated launch timelines


  • Summary of clinical trial deep dive


  • Overview of differentiation strategy

See other case studies

Commercial Strategy case studies >

Oncology case studies >

Service Areas Details

Commercial Strategy (Competitive assessment)

Therapeutic Areas Details

Oncology (Solid Tumor, Immuno-oncology)

© 2019, First Principles Advisory Group. All Rights Reserved
SF Bay Area, Denver, Seattle, New York City, Cambridge
First Principles Advisory Group
1290 Howard Street Suite 323
Burlingame, CA 94010
(415) 669-5183
info@fpadvisory.net